Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: Should it, could it be back to the $2 range... Why not.

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

Should it, could it be back to the $2 range... Why not.

BostonCA

Jan 12, 2012 05:02PM

karlwest

Rank: Vice President [?]

Points: 1525 [?]

Votes: 42 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Should it, could it be back to the $2 range... Why not.

in response to

Should it, could it be back to the $2 range... Why not.

BostonCA

posted on Jan 12, 2012 05:30PM

Boston,

I like where you're going with this, all good stuff. However, the market being $200 Billion were numbers used in the 2006 time frame, long before smartphones and tablet computers went mainstream. My thoughts are the $200B figure is closer to $400B and rising.

Great day longs, here's to more green days! all my opinion. kw

8 Recommendations

Re: Should it, could it be back to the $2 .... Do Not Mean to be Rude..

marc

Jan 12, 2012 05:31PM

Re: Should it, could it be back to the $2 .... Do Not Mean to be Rude..

pandg222

Jan 12, 2012 10:01PM

Re: Should it, could it be back to the $2 .... Do Not Mean to be Rude..

pandg222

Jan 12, 2012 10:11PM

Re: Should it, could it be back to the $2 .... Pandg222